Tampa, FL: CoreRx, Inc. is pleased to announce they are now occupying their new 35,000 square foot facility in Clearwater, FL. This distinct facility will enable CoreRx’s scientific staff to custom formulate, analyze and manufacture the highest quality pharmaceutical products for their client-partners.
Their new complex will encompass nearly four times their former site and will more than triple per day production capacity, reinforcing CoreRx’s status as a leader in the pharmaceutical contract development and manufacturing industry. Enhancements are continually made their already strong record of providing the most outstanding customer service in the business while helping their customer-partners grow their share of the pharmaceutical industry.
CoreRx’s new plant is a high-capacity Good Manufacturing Practices (GMP) certified facility equipped with the latest Trane catalytic air cleaning system and climate-control systems for temperature, humidity and air quality. The analytical laboratories, outfitted with the latest scientific instrumentation, ensure that all products are tested and released to the highest standards of quality.
The flexible facility together with CoreRx’s cross-trained, multi-skilled work force ensures fast processing times, high-tech manufacturing capability, extensive excipient and packaging component inventory, superior customer service, and overall cost control. CoreRx’s expanded new facility allows them to quickly and efficiently transform their customer’s concepts into reality and manufacture products in order to shorten client’s time to the clinic and ultimately to the commercial marketplace. Fully appreciating that time-to-market is critical, CoreRx offers remarkably flexible, affordable, and rapid outsourcing services designed to meet clients’ specific development and manufacturing needs. CoreRx’s clients represent both small and large companies, within the pharmaceutical and biotechnology industries, and academic institutions who have a focus on clinical studies.
About CoreRx
CoreRx is a contract research organization providing customized preformulation services, formulation development, manufacturing, and analytical services to pharmaceutical, biotechnology, academic, and veterinary clients. The company is renowned for reliably expediting early development activities to speed potential drugs to clinical trials while applying stage-specific scientific knowledge and experience. CoreRx’s unique corporate structure creates project teams that work intensively with each client, bringing an extension of their own organization into the CoreRx lab.
As a fully cGMP contract facility, CoreRx provides formulation development, analytical, and clinical material resources, utilizing a variety of multi-layer tablet equipment for combination products. CoreRx also offers development and manufacture of multi-particulate combination drug products. Whether your need is for multiple tablets in a capsule, pellets, granules, nano-particles, co-processed spray dried powders or multiple powders in capsules, CoreRx has you covered.
Keep on top of new developments and throughout the drug development industry by following us on Twitter www.twitter.com/CoreRx. For more detailed information about us, visit www.corerxpharma.com.
